Mechanism action of Bupranolol
Bupranolol competes with sympathomimetic neurotransmitters such as
catecholamines for binding at beta(1)-adrenergic receptors in the heart,
inhibiting sympathetic stimulation. This results in a reduction in
resting heart rate, cardiac output, systolic and diastolic blood
pressure, and reflex orthostatic hypotension.
No comments:
Post a Comment